MDM2 and breast cancer: In contrast, the transfection of a dominant-negative NFAT (DN-NFAT) (Figure 2C) or NFAT1 siRNA (Figure 2D) led to the downregulation of MDM2 expression, which was further enhanced by JapA in both breast cancer cell lines.